Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Gross Margin (2024 - 2025)

Indivior Pharmaceuticals has reported Gross Margin over the past 2 years, most recently at 81.56% for Q4 2025.

  • Quarterly results put Gross Margin at 81.56% for Q4 2025, down 205.0% from a year ago — trailing twelve months through Dec 2025 was 80.08% (down 41.0% YoY), and the annual figure for FY2025 was 80.23%, down 33.0%.
  • Gross Margin for Q4 2025 was 81.56% at Indivior Pharmaceuticals, up from 73.25% in the prior quarter.
  • Over the last five years, Gross Margin for INDV hit a ceiling of 86.62% in Q1 2024 and a floor of 73.25% in Q3 2025.